# BGMS — Bio Green Med Solution Inc · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** BGMS  
**Sources:** 18  
**Published:** 2026-10-12  
**Canonical:** https://app.k3vl4r.com/research/deep-research-bgms-bio-green-med-solution-inc-catalysts-narrative-risk-7168

---

# Bio Green Med Solution, Inc. (BGMS) — Point-in-Time Research (as of 2026-10-12)

**Important context (not a finding, provided as background):** BGMS is a micro-cap listed on Nasdaq Capital Market (also referenced in Malaysia), formerly Cyclacel Pharmaceuticals, Inc., which rebranded in September 2022 and later pivoted from clinical-stage biopharmaceuticals to fire safety distribution [[16]](https://stockanalysis.com/stocks/bgms/). As of 2026-10-10, it carried a market cap of approximately $5.62M [[15]](https://finance.yahoo.com/quote/BGMS/), [[16]](https://stockanalysis.com/stocks/bgms/).

## Recent Catalysts (last ~1–3 months)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-bgms-bio-green-med-solution-inc-catalysts-narrative-risk-7168 (free to sign up)._
